ConductScience.org, home

Paper35656199

Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.

Cruz KCP and 2 others. Front Bioeng Biotechnol, 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Papers, record 35656199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35656199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.
PubMed
Journal
Front Bioeng Biotechnol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.76
iCite
Revised in PubMed
2022-07-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cruz KCPKarla Cristina P
2Enekegho LOLaura O
3Stuart DTDavid T

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References193

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133540694Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against Clostridioides difficile.Microorganisms2021https://conductscience.org/library/papers/33540694PubMed
231936328Protection Efficacy of Oral Bait Probiotic Vaccine Constitutively Expressing Tetravalent Toxoids against Clostridium perfringens Exotoxins in Livestock (Rabbits).Vaccines (Basel)2020https://conductscience.org/library/papers/31936328PubMed
333968585Role of probiotics in prevention and treatment of enteric infections: a comprehensive review.3 Biotech2021https://conductscience.org/library/papers/33968585PubMed
432824911Selective Eradication of Staphylococcus aureus by the Designer Genetically Programmed Yeast Biocontrol Agent.Antibiotics (Basel)2020https://conductscience.org/library/papers/32824911PubMed
523685029Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system.Anaerobe2013https://conductscience.org/library/papers/23685029PubMed
612672861Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.N Engl J Med2003https://conductscience.org/library/papers/12672861PubMed
730687250A Novel Bacteriophage Lysin-Human Defensin Fusion Protein Is Effective in Treatment of Clostridioides difficile Infection in Mice.Front Microbiol2018https://conductscience.org/library/papers/30687250PubMed
822906361Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity.Annu Rev Med2013https://conductscience.org/library/papers/22906361PubMed
930082713An update on the human and animal enteric pathogen Clostridium perfringens.Emerg Microbes Infect2018https://conductscience.org/library/papers/30082713PubMed
1031177350Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production.J Ind Microbiol Biotechnol2019https://conductscience.org/library/papers/31177350PubMed
1117236612Growth promoting antibiotics in food animal production: an economic analysis.Public Health Rep2007https://conductscience.org/library/papers/17236612PubMed
1232985336Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection.Gut Microbes2020https://conductscience.org/library/papers/32985336PubMed
1329524545Expression of the alpha toxin of Clostridium perfringens in Lactobacillus casei genome and evaluation of its immune effects in mice.Microb Pathog2018https://conductscience.org/library/papers/29524545PubMed
1418779344Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis.Infect Immun2008https://conductscience.org/library/papers/18779344PubMed
1534180341The Interface of Vibrio cholerae and the Gut Microbiome.Gut Microbes2021https://conductscience.org/library/papers/34180341PubMed
1632255488SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.Clin Infect Dis2021https://conductscience.org/library/papers/32255488PubMed
1730238983Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections.Ann N Y Acad Sci2019https://conductscience.org/library/papers/30238983PubMed
1828676714A brief history of antibiotics and select advances in their synthesis.J Antibiot (Tokyo)2018https://conductscience.org/library/papers/28676714PubMed
1920543037Targeted chromosomal knockouts in Mycoplasma pneumoniae.Appl Environ Microbiol2010https://conductscience.org/library/papers/20543037PubMed
2016728323Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials.Lancet Infect Dis2006https://conductscience.org/library/papers/16728323PubMed

See all 193 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42020676Gene Exchange Mechanisms in Natural and Engineered Probiotics Within the Human Gut Implications for Antibiotic Resistance and Metabolic Modulation.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/42020676PubMed
41975425From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics.Microb Cell Fact2026https://conductscience.org/library/papers/41975425PubMed
41882398Microbial Biotechnology in Medicine.Prog Mol Subcell Biol2026https://conductscience.org/library/papers/41882398PubMed
41877779The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision.Front Med (Lausanne)2026https://conductscience.org/library/papers/41877779PubMed
41823362Precision Microbial Therapeutics for Infertility: Next-Generation Probiotics, Engineered Biologics and Translational Pathways.Microb Biotechnol2026https://conductscience.org/library/papers/41823362PubMed
41505076Designing the Next Generation of Endolysins: A Triple Strategy Integrating Bioinformatics Mining, Engineering Modification and Encapsulation Formulation.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/41505076PubMed
41438195
Study to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.
Front Nutr2025https://conductscience.org/library/papers/41438195PubMed
39877756Water pollution, cholera, and the role of probiotics: a comprehensive review in relation to public health in Bangladesh.Front Microbiol2024https://conductscience.org/library/papers/39877756PubMed
39597673Assessment of Biofilm Formation and Anti-Inflammatory Response of a Probiotic Blend in a Cultured Canine Cell Model.Microorganisms2024https://conductscience.org/library/papers/39597673PubMed
39588716Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions.J Agric Food Chem2024https://conductscience.org/library/papers/39588716PubMed
39531149Bioengineered Probiotics for Clostridioides difficile Infection: An Overview of the Challenges and Potential for This New Treatment Approach.Probiotics Antimicrob Proteins2025https://conductscience.org/library/papers/39531149PubMed
39392836Microbes as medicine.Ann N Y Acad Sci2024https://conductscience.org/library/papers/39392836PubMed
39106212Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques.Gut Microbes2024https://conductscience.org/library/papers/39106212PubMed
37309041Engineered Bacillus subtilis alleviates intestinal oxidative injury through Nrf2-Keap1 pathway in enterotoxigenic Escherichia coli (ETEC) K88-infected piglet.J Zhejiang Univ Sci B2023https://conductscience.org/library/papers/37309041PubMed
37106999About Functional Foods: The Probiotics and Prebiotics State of Art.Antibiotics (Basel)2023https://conductscience.org/library/papers/37106999PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35656199

GET https://conductscience.org/api/papers/v1/35656199/references?page=2